Aurobindo Pharma acquires Pharmacin International B.V

16195 Investors following Aurobindo Pharm. Share this News with them.

0

Like this story, share it with millions of investors on M3

Aurobindo Pharma acquires Pharmacin International B.V

Aurobindo pharma acquires Pharmacin International B.V., in Netherlands extending its European presence.

Post your opinion here

 

0

Tweet

Share on Tumblr

RELATED NEWS Aurobindo Pharma buys Dutch firm Pharmacin Aurobindo Pharma can easily go upto Rs 750 Aurobindo Pharma set to acquire Senor Organics Aurobindo receives another approval from MCC South Africa Aurobindo posts landmark results in Q2 ALSO READ See latest News about Aurobindo Pharm See previous management interviews See what other Experts & Brokerages are saying about Aurobindo Pharm Aurobindo Pharm BSE | NSE 29/05/12 Are Mutual Funds betting on Aurobindo Pharm?

Pharmacin has established relationships within the industry and has obtained substantial market coverage in Europe. Aurobindo expects to build on these relationships to participate in the generic pharmaceuticals value chain. The product portfolio of Aurobindo, the manufacturing and r&d capabilities are expected to help strengthen and grow the relationships of Pharmacin. Aurobindo would stand to benefit as this acquisition would provide an opportunity to expand into several markets in Europe with a dependable infrastructure and proven relationships.

This is Aurobindo's second acquisition in Europe, after acquiring Milpharm Limited in UK in early 2006. Aurobindo believes that such acquisitions reduce the time to market and enhance the relationships in the generic value chain in addition to building a broad and formidable product portfolio.

Motilal Oswal Investment Advisors Private Limited, was the lead advisor to Aurobindo Pharma Ltd on the transaction.

Sourced From: Aurobindo Pharma Limited